Breaking News

BiondVax Pharmaceuticals Rebrands as Scinai Immunotherapeutics

Reflects a new focus on the development of inflammation and immunology therapeutics and expansion into CDMO business.

BiondVax Pharmaceuticals Ltd., a biopharmaceutical company, has changed its corporate name to Scinai Immunotherapeutics Ltd. to reflect a new focus on the development of inflammation and immunology therapeutics. Recently, the company revamped its senior management team and pharmaceuticals development programs along with expansion into the contract development and manufacturing organization (CDMO) business under the banner Scinai Bioservices. Scinai offers a multitude of services to support bi...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters